Phylex BioSciences Publishes Positive Results of Protection Study Against SARS-CoV-2 Delta Variant with its Second Generation mRNA Vaccine
March 23, 2022
DEL MAR, California – March 23, 2022 – Two years into the COVID-19 pandemic there is still a... Read More
Phylex BioSciences Announces Development of SARS-CoV-2 Delta and Omicron Bivalent Vaccine for 2022
December 6, 2021
DEL MAR, California – December 6, 2021 – The new omicron variant is a game changer as current vaccine... Read More
New Variant in France Highlights the Challenge for Current Vaccines
April 1, 2021
DEL MAR, California – April 1, 2021 – French virologists in hospital Henri Mondor near Paris reported... Read More
New UK and South Africa Variants Confirm Need for Universal SARS Coronavirus Vaccine
December 28, 2020
DEL MAR, California – December 28, 2020 – Two weeks ago the UK reported a new variant of the SARS-CoV-2... Read More
Newly Discovered Mutation in Mink Farms Highlights Need for Universal SARS Coronavirus Vaccine
November 7, 2020
DEL MAR, California – November 7, 2020 – In a press conference this week Mette Frederiksen, Prime... Read More
ATUM and Phylex BioSciences Collaborate to Accelerate the Development of a Universal SARS Coronavirus Vaccine
June 15, 2020
NEWARK and DEL MAR, Calif. – June 15, 2020 – ATUM and Phylex BioSciences have entered into a... Read More